Hollister-Stier Laboratories sold exclusive worldwide rights to Twinject to Verus Pharmaceuticals

Jul. 2005

Client: Hollister-Stier Laboratories is a leading allergy products provider and contract manufacturer for fill and finish of lyophilized and other specialty preparation pharmaceuticals

Role: Edgemont Partners acted as exclusive financial advisor to Hollister-Stier Laboratories in the sale of its exclusive rights to TwinJect Epinephrine Auto-Injector to Verus Pharmaceuticals

Location: Spokane, WA

Sector: Pharmaceutical Services

Lead Banker: David Blume

View Press Release